“Eric’s breadth of experience in developing and executing integrated strategies to drive rapid growth represents a key addition to our executive team,” said Frank Attardo, president of Galt Medical and NeedleTech Products. “I am pleased to have a leader of Eric’s caliber on board to drive our sales and marketing efforts. His skills in identifying opportunities, setting direction, developing teams, and building external relationships will contribute substantially to our long-term success.”
Meyers is a 25-year veteran in the medical device and pharmaceutical industries. Most recently, he served as vice president of marketing, product management and sales for Virtify Inc., eventually serving as interim CEO. His experience includes leading sales, marketing, product management, and product development activities, as well as strategic planning and execution.
“The addition of Eric Meyers as head of sales and marketing for Galt and NeedleTech reinforces our continued confidence in the growth opportunity in these businesses,” noted Frank Tarallo, CEO of Theragenics Corporation. “Eric has an impressive record of accomplishment and a proven ability to provide both the strategic and the tactical leadership to deliver profitable growth. We welcome Eric as he joins our organization.”
Theragenics Corporation's surgical products business manufactures and distributes wound closure, vascular access, and specialty needle products. The surgical segment serves a number of markets including interventional cardiology, interventional radiology, vascular surgery, orthopedics, plastic surgery, dental surgery, urology, veterinary medicine, pain management, endoscopy, and spinal surgery. Theragenics’ brachytherapy business manufactures and sells products used primarily in the minimally invasive treatment of localized prostate cancer and breast cancer.